Packapill, an Australian medication delivery startup, has teamed up with Western Diagnostics Pathology Healius Limited to offer teleconsultation services. The partnership signifies a major expansion for the company, which, until now, had only provided prescription drug deliveries.
The launch of the telehealth offering came after the two companies trailed the service and found high levels of demand from Australian consumers seeking general practice support. In fact, during the trial, over 4,000 patients called in looking to sign up for the service.
"The demand for this feature confirms the need to extend health services to platforms that are readily accessible to use. We’re excited to launch the Consult feature wider to all Australians in the coming weeks," said Packapill co-founder Lenin Rajendran.
Image Credit: Packapill
What's Driving This Trend
- Teleconsultation Services
- The increasing demand for telehealth services in Australia represents an opportunity for startups to expand their offerings beyond medication delivery.
- Virtual General Practice Support
- Startups can disrupt the traditional healthcare industry by offering virtual general practice support that is easily accessible and convenient for patients.
- Platform Expansion
- The success of Packapill's partnership with Western Diagnostics Pathology Healius Limited highlights a trend of startups expanding their platform offerings beyond their initial focus.
Who This Affects Most
- Healthcare
- Startups in the healthcare industry can take advantage of the increasing demand for telehealth services and offer virtual general practice support to patients.
- Telemedicine
- The telemedicine industry can benefit from the success of Packapill's teleconsultation service and expand their offerings to meet the growing demand from patients.
- Logistics
- Logistics companies can partner with startups offering teleconsultation services to provide medication delivery and expand their services beyond traditional transportation.
